Bionime Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Bionime.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
Medical Equipment earnings growth | 19.6% |
Revenue growth rate | n/a |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 17 Jan 2024 |
Recent future growth updates
Recent updates
These Return Metrics Don't Make Bionime (TPE:4737) Look Too Strong
Apr 29Looking For Steady Income For Your Dividend Portfolio? Is Bionime Corporation (TPE:4737) A Good Fit?
Mar 23Did You Participate In Any Of Bionime's (TPE:4737) Respectable 83% Return?
Mar 05Should You Use Bionime's (TPE:4737) Statutory Earnings To Analyse It?
Feb 15Bionime (TPE:4737) Has A Somewhat Strained Balance Sheet
Feb 01How Has Bionime (TPE:4737) Allocated Its Capital?
Jan 19A Closer Look At Bionime Corporation's (TPE:4737) Uninspiring ROE
Jan 06A Look At The Fair Value Of Bionime Corporation (TPE:4737)
Dec 22Bionime Corporation (TPE:4737) Investors Should Think About This Before Buying It For Its Dividend
Dec 09Bionime (TPE:4737) Has Compensated Shareholders With A Respectable 50% Return On Their Investment
Nov 24Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2024 | 2,098 | 72 | 404 | 454 | 1 |
12/31/2023 | 1,756 | 6 | -238 | 203 | N/A |
9/30/2023 | 1,863 | 22 | -163 | 297 | N/A |
6/30/2023 | 2,002 | 43 | -109 | 284 | N/A |
3/31/2023 | 2,150 | 72 | 26 | 394 | N/A |
12/31/2022 | 2,211 | 91 | -171 | 142 | N/A |
9/30/2022 | 2,091 | 95 | -189 | 91 | N/A |
6/30/2022 | 2,023 | 115 | -139 | 129 | N/A |
3/31/2022 | 1,862 | 89 | -208 | 84 | N/A |
12/31/2021 | 1,850 | 87 | -15 | 270 | N/A |
9/30/2021 | 1,879 | 101 | 2 | 254 | N/A |
6/30/2021 | 1,832 | 111 | -58 | 205 | N/A |
3/31/2021 | 1,779 | 83 | -62 | 204 | N/A |
12/31/2020 | 1,669 | 62 | -79 | 218 | N/A |
9/30/2020 | 1,913 | 73 | -20 | 270 | N/A |
6/30/2020 | 1,951 | 38 | -4 | 247 | N/A |
3/31/2020 | 2,162 | 91 | 248 | 456 | N/A |
12/31/2019 | 2,173 | 106 | 267 | 406 | N/A |
9/30/2019 | 2,043 | 112 | 117 | 243 | N/A |
6/30/2019 | 2,113 | 132 | 55 | 208 | N/A |
3/31/2019 | 1,986 | 121 | -98 | 64 | N/A |
12/31/2018 | 2,007 | 128 | -47 | 122 | N/A |
9/30/2018 | 1,962 | 114 | 2 | 164 | N/A |
6/30/2018 | 1,842 | 135 | 40 | 166 | N/A |
3/31/2018 | 1,821 | 137 | -34 | 99 | N/A |
12/31/2017 | 1,820 | 150 | -93 | 30 | N/A |
9/30/2017 | 1,771 | 174 | N/A | 134 | N/A |
6/30/2017 | 1,780 | 181 | N/A | 275 | N/A |
3/31/2017 | 1,791 | 192 | N/A | 420 | N/A |
12/31/2016 | 1,740 | 179 | N/A | 458 | N/A |
9/30/2016 | 1,654 | 143 | N/A | 441 | N/A |
6/30/2016 | 1,637 | 119 | N/A | 373 | N/A |
3/31/2016 | 1,571 | 91 | N/A | 228 | N/A |
12/31/2015 | 1,610 | 99 | N/A | 200 | N/A |
9/30/2015 | 1,634 | 101 | N/A | 271 | N/A |
6/30/2015 | 1,591 | 82 | N/A | 305 | N/A |
3/31/2015 | 1,571 | 72 | N/A | 354 | N/A |
12/31/2014 | 1,525 | 54 | N/A | 360 | N/A |
9/30/2014 | 1,446 | 22 | N/A | 272 | N/A |
6/30/2014 | 1,459 | 43 | N/A | 148 | N/A |
3/31/2014 | 1,536 | 72 | N/A | 165 | N/A |
12/31/2013 | 1,561 | 90 | N/A | 129 | N/A |
9/30/2013 | 1,513 | 91 | N/A | 102 | N/A |
6/30/2013 | 1,505 | 84 | N/A | 135 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if 4737's forecast earnings growth is above the savings rate (0.8%).
Earnings vs Market: Insufficient data to determine if 4737's earnings are forecast to grow faster than the TW market
High Growth Earnings: Insufficient data to determine if 4737's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if 4737's revenue is forecast to grow faster than the TW market.
High Growth Revenue: Insufficient data to determine if 4737's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 4737's Return on Equity is forecast to be high in 3 years time